Drug Trial Radar · NCT03068442
The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition
Last checked: Nov 20, 2026Latest source record: May 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
45
Planned (sponsor's estimate)
Start
Feb 17, 2017
Primary completion
Sep 10, 2030
Study completion Sep 10, 2030
Sponsor
- Lead sponsor
- Scott McnallyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- American Heart Association
- First posted
- Mar 1, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The invesigators propose a clinical study on patients undergoing carotid surgery (endarterectomy). The invesigators will determine carotid artery imaging features associated with (1) vessel wall inflammation, (2) downstream brain inflammation, and (3) cognitive benefit from surgery. This project will uncover links between inflamed carotid plaque and downstream brain inflammation. The invesigators will also determine carotid plaque imaging features predicting cognitive benefit from carotid surgery.
Conditions
- Cognitive Impairment
- Carotid Artery Plaque
- Inflammation
Interventions
Imaging with flutemetamol F 18 PET/CTDrug
All subjects will undergo diagnostic imaging as the intervention. This imaging will be with flutemetamol F 18 PET/CT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Carotid intraplaque hemorrhage correlation with carotid plaque inflammation on immunohistochemistry.Time frame: baseline
- Carotid MRI-detected intraplaque hemorrhage and prediction of brain inflammation on PET/CT.Time frame: baseline
- Preoperative MRI-detected carotid intraplaque hemorrhage and prediction of cognitive improvement after endarterectomy.Time frame: Change from baseline at 3 month followup
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Utah
Salt Lake City, Utah
George E. Wahlen Department of Veterans Affairs Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.